Urothelial Carcinoma Recurrent
Also known as: Recurrent Urothelial Carcinoma / Transitional cell carcinoma recurrent
Drug | Drug Name | Drug Description |
---|---|---|
DB12768 | BCG vaccine | A vaccine indicated in the prevention of tuberculosis and the treatment of non-invasive urothelial bladder cancer. |
Drug | Drug Name | Target | Type |
---|
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB08875 | Cabozantinib | 1 | Active Not Recruiting | 1 |
DB13007 | Enfortumab vedotin | 1 | Recruiting | 1 |
DB12147 | Erdafitinib | 1 | Recruiting | 1 |
DB00441 | Gemcitabine | 1 | Recruiting | 1 |
DB00724 | Imiquimod | 1 | Recruiting | 1 |
DB09035 | Nivolumab | 1 | Active Not Recruiting | 1 |
DB15632 | Zalifrelimab | 1 | Recruiting | 1 |
DB08871 | Eribulin | 1 / 2 | Active Not Recruiting | 1 |
DB11714 | Durvalumab | 2 | Not Yet Recruiting | 1 |
DB09035 | Nivolumab | 2 | Recruiting | 1 |
DB15102 | Pemigatinib | 2 | Recruiting | 1 |
DB14851 | Relatlimab | 2 | Recruiting | 1 |
DB15310 | Vactosertib | 2 | Not Yet Recruiting | 1 |
DB12768 | BCG vaccine | 3 | Not Yet Recruiting | 1 |
DB16648 | Bacillus calmette-guerin substrain russian BCG-I live antigen | 3 | Not Yet Recruiting | 1 |
DB10343 | Bacillus calmette-guerin substrain tice live antigen | 3 | Not Yet Recruiting | 1 |
DB00305 | Mitomycin | Not Available | Available | 1 |
DB00305 | Mitomycin | Not Available | Recruiting | 1 |